by Plus Therapeutics | Feb 6, 2026 | GBM
ReSPECT Clinical Trial’s Dr. Brenner recently participated in another Stand Up To Cancer® (SU2C) Innovation Summit, focused on advancing novel approaches for the detection and treatment of gliomas, a complex and aggressive form of brain cancer. The summit...
by Plus Therapeutics | Feb 4, 2026 | Uncategorized
On World Cancer Day, Plus Therapeutics proudly joins the global oncology community to raise awareness of cancer and reaffirm a shared commitment to improving access to high‑quality, equitable care for patients worldwide. Established in 2000 by the Union for...
by Plus Therapeutics | Jan 29, 2026 | Uncategorized
Marc Hedrick, President & CEO of Plus Therapeutics, recently joined Karen Jagoda on the Empowered Patient Podcast for an in‑depth discussion on the company’s mission to advance care for patients with central nervous system (CNS) cancers. During the interview, Dr....
by Plus Therapeutics | Jan 20, 2026 | Uncategorized
Plus Therapeutics and CNSide Diagnostics are pleased to participate in the Inaugural Brain & Spine Metastases Conference, taking place this Thursday in Miami, Florida. The event brings together leading clinicians, researchers, and innovators focused on advancing...
by Plus Therapeutics | Jan 12, 2026 | LM
Plus Therapeutics is proud to collaborate with CNSide Diagnostics and the Leptomeningeal Cancer Foundation on the development of a new educational resource designed to support individuals affected by leptomeningeal metastases (LM), as well as their caregivers and...
Recent Comments